Page 1 of Clinical Trials for Incyte Corporation [SPONSOR-COLLABORATORS], 37 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Dose Ranging Study of the Effect of INCB018424 Phosphate Cream When Applied to Patients With Plaque Psoriasis
Last Updated: March 13, 2012
Condition(s): Plaque Psoriasis
2
Completed
A Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor (Ruxolitinib; INBC018424) in Patients With Multiple Myeloma
Last Updated: January 20, 2012
Condition(s): Relapsed Multiple Myeloma; Refractory Multiple Myeloma; Multiple Myeloma
3
Recruiting
Study of Ruxolitinib in Pancreatic Cancer Patients
Last Updated: May 1, 2012
Condition(s): Metastatic Pancreatic Adenocarcinoma
4
Recruiting
A Dose-escalation Study in Subjects With Advanced Malignancies
Last Updated: January 20, 2012
Condition(s): Advanced Malignancies
5
Completed
A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes
Last Updated: January 20, 2012
Condition(s): Insulin Resistance; Obesity
6
Completed
Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients
Last Updated: January 20, 2012
Condition(s): HIV Infections
7
Completed
Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects
Last Updated: March 13, 2012
Condition(s): Diabetes Mellitus Type 2;; Obesity
8
Completed
Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics
Last Updated: March 13, 2012
Condition(s): Type 2 Diabetes
9
Active, not recruiting
Study to Determine the Safety and Efficacy of Ruxolitinib (INCB018424) in Patients With Polycythemia Vera or Essential Thrombocythemia
Last Updated: March 5, 2012
Condition(s): Polycythemia Vera; Essential Thrombocythemia
10
Terminated
Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer
Last Updated: January 20, 2012
Condition(s): Breast Cancer
11
Completed
A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis
Last Updated: June 28, 2010
Condition(s): Rheumatoid Arthritis
12
Recruiting
Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)
Last Updated: April 20, 2012
Condition(s): Polycythemia Vera
13
Completed
A Study of INCB018424 Phosphate Cream When Applied to Patients With Plaque Psoriasis
Last Updated: March 13, 2012
Condition(s): Plaque Psoriasis
14
Completed
Study of INCB018424 Sustained Release Formulation in Myelofibrosis Patients
Last Updated: March 13, 2012
Condition(s): Myelofibrosis
15
Completed
Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors
Last Updated: January 20, 2012
Condition(s): Solid Tumors
16
Recruiting
A Dose-escalation Study in Subjects With Advanced Malignancies
Last Updated: April 10, 2012
Condition(s): Advanced Malignancies
17
Recruiting
Alternative Dosing Strategy of Ruxolitinib in Patients With Myelofibrosis
Last Updated: March 13, 2012
Condition(s): Primary Myelofibrosis; Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
18
Terminated
A Study to Test the Safety and Effectiveness of Dexelvucitabine, an Investigational Nucleoside Reverse Transcriptase Inhibitor (NRTI), to Lamivudine, an Approved NRTI, in HIV Treatment-Experienced Patients Who Are Resistant to Protease Inhibitors, NRTIs and Non-NRTIs
Last Updated: March 13, 2012
Condition(s): HIV Infections; Human Immunodeficiency Virus
19
Terminated
Open Label Trial of INCB07839 to Determine Effect and Safety of INCB007839 Plus Trastuzumab in HER2 Positive Metastatic Breast Cancer
Last Updated: January 20, 2012
Condition(s): Metastatic Breast Cancer
20
Recruiting
Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (PET-MF)
Last Updated: March 13, 2012
Condition(s): Myelofibrosis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Incyte+Corporation

Page 1 of Clinical Trials for Incyte Corporation [SPONSOR-COLLABORATORS], 37 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About